Endothelial dysfunction and subclinical atheromatosis in patients with systemic sclerosis

被引:0
作者
Gonzalez-Martin, J. J. [1 ]
Novella-Navarro, M. [1 ]
Calvo-Aranda, E. [1 ]
Cabrera-Alarcon, J. L. [3 ]
Carrion, O. [2 ]
Abdelkader, A. [2 ]
Aramburu, F. [1 ]
Alcocer, P. [1 ]
Sainz, F. [2 ]
Garcia De La Pena, P. [1 ]
机构
[1] Univ Hosp HM Sanchinarro, Dept Rheumatol, Avda Manoteras 10, Madrid 28050, Spain
[2] Univ Hosp HM Sanchinarro, Dept Angiol & Vasc Surg, Madrid, Spain
[3] Natl Cardiovasc Res Ctr CNIC, Madrid, Spain
关键词
endothelial dysfunction; systemic sclerosis; atherosclerosis; flow-mediated vasodilation; intima-media thickness; scleroderma; vasculopathy; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BRACHIAL-ARTERY; VITAMIN-D; VASCULAR DYSFUNCTION; RAYNAUDS-PHENOMENON; RISK-FACTORS; ATHEROSCLEROSIS; VASODILATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess subclinical vascular features in patients with systemic sclerosis (SSc) via carotid ultrasound, and flow-mediated vasodilation (FMD), as measures of cardiovascular risk (CVR). Methods. This was a cross-sectional study of 70 patients diagnosed with SSc (diffuse or limited forms), on whom a vascular study protocol was performed to assess angiodynamic parameters measured by FMD in brachial artery and carotid ultrasound lesions: carotid intima-media thickness (CIMT) and carotid atheroma plaques (AP). Classical CVR factors were also assessed, as well as main features of SSc regarding skin and organic involvement, laboratory parameters, presence of autoantibodies and specific treatments. Results. 94% of patients were women with a mean age of 50.2 +/- 12.5 years. 84% had endothelial dysfunction (ED), being severe in 49%, statistically associated with glucocorticoid (GC) treatment (OR=8.78; CI=1.52-50.78; p=0.015). CIMT was pathological in 39%, 23% had AP (none had significative haemodymanic stenosis). Serum vitamin D concentration (25(OH)D3) showed a protective effect on CIMT (OR=0.94; CI=0.89-0.99; p=0.025). No differences between types of SSc were obtained; neither association between SSc features and classical CVR factors. Conclusions. GC treatment has implications in CVR, despite in SSc GC doses administered are lower than in other autoimmune diseases (in our cohort even prednisone <= 10 mg daily was associated with ED). GC may be associated with an early vascular damage in these patients, which could lead to changes in FMD, ED and finally AP. On the other hand, optimum levels of 25(OH)D3 seemed to be beneficial against vascular damage.
引用
收藏
页码:S48 / S52
页数:5
相关论文
共 37 条
[1]   Premature atherosclerosis in systemic sclerosis patients: Its relation to disease parameters and to traditional risk factors [J].
Abdou, Manal M. Sedky ;
El Desouky, Soha M. ;
El Kaffas, Khaled M. Helmy ;
Hassan, Abeer M. Ahmed .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (03) :383-389
[2]   Vitamin D Status Is Associated With Arterial Stiffness and Vascular Dysfunction in Healthy Humans [J].
Al Mheid, Ibhar ;
Patel, Riyaz ;
Murrow, Jonathan ;
Morris, Alanna ;
Rahman, Ayaz ;
Fike, Lucy ;
Kavtaradze, Nino ;
Uphoff, Irina ;
Hooper, Craig ;
Tangpricha, Vin ;
Alexander, R. Wayne ;
Brigham, Kenneth ;
Quyyumi, Arshed A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (02) :186-192
[3]   Assessment of vascular function in systemic sclerosis -: Indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production [J].
Andersen, G ;
Mincheva-Nilsson, L ;
Kazzam, E ;
Nyberg, G ;
Klintland, N ;
Petersson, AS ;
Rantapää-Dahlqvist, S ;
Waldenström, A ;
Caidahl, K .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1324-1332
[4]  
[Anonymous], MON INT
[5]   Atherosclerosis in Systemic Sclerosis A Systematic Review and Meta-Analysis [J].
Au, Karen ;
Singh, Manjit K. ;
Bodukam, Vijay ;
Bae, Sangmee ;
Maranian, Paul ;
Ogawa, Rikke ;
Spiege, Brennan ;
McMahon, Maureen ;
Hahn, Bevra ;
Khanna, Dinesh .
ARTHRITIS AND RHEUMATISM, 2011, 63 (07) :2078-2090
[6]   Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention [J].
Bard, RL ;
Kalsi, H ;
Rubenfire, M ;
Wakefield, T ;
Fex, B ;
Rajagopalan, S ;
Brook, RD .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08) :1030-1032
[7]   Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis [J].
Bartoli, Francesca ;
Blagojevic, Jelena ;
Bacci, Marzia ;
Fiori, Ginevra ;
Tempestini, Alessio ;
Conforti, Maria Letizia ;
Guiducci, Serena ;
Miniati, Irene ;
Di Chicco, Mauro ;
Del Rosso, Angela ;
Perfetto, Federico ;
Castellani, Sergio ;
Pignone, Alberto ;
Cerinic, Marco Matucci .
AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 :283-290
[8]   Very low levels of vitamin D in systemic sclerosis patients [J].
Caramaschi, Paola ;
Dalla Gassa, Alessandra ;
Ruzzenente, Orazio ;
Volpe, Alessandro ;
Ravagnani, Viviana ;
Tinazzi, Ilaria ;
Barausse, Giovanni ;
Bambara, Lisa M. ;
Biasi, Domenico .
CLINICAL RHEUMATOLOGY, 2010, 29 (12) :1419-1425
[9]   Carotid and femoral arterial wall mechanics in scleroderma [J].
Cheng, KS ;
Tiwari, A ;
Boutin, A ;
Denton, CP ;
Black, CM ;
Morris, R ;
Hamilton, G ;
Seifalian, AM .
RHEUMATOLOGY, 2003, 42 (11) :1299-1305
[10]   Incidence and prevalence of systemic sclerosis: A systematic literature review [J].
Chifflot, Helene ;
Fautrel, Bruno ;
Sordet, Christelle ;
Chatelus, Emmanuel ;
Sibilia, Jean .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (04) :223-235